Life sciences news
-
miDiagnostics welcomes Nicolas De Clercq as its new Chief Financial Officer
Wednesday March 30th 2022
Read more
-
Rejuvenate Biomed started a groundbreaking clinical trial and expands for future growth
Tuesday March 29th 2022
Read more
-
Bone Therapeutics to strategically focus on lead cell therapy product ALLOB
Tuesday March 29th 2022
Read more
-
2021 was a record year for Flanders’ exports
Tuesday March 29th 2022
Read more
-
eTheRNA Manufacturing announces new LNP formulation development and production service
Tuesday March 29th 2022
Read more
-
Jyseleca® approved in Japan for ulcerative colitis
Monday March 28th 2022
Read more
-
New incubator biotope by VIB launches to support biotech startup teams on their journey to success
Thursday March 24th 2022
Read more
-
Flanders crowns 3 foreign investors
Wednesday March 23rd 2022
Read more
-
Become a flanders.bio member
Your news here?
-
argenx announces positive topline Phase 3 data from ADAPT-SC study evaluating subcutaneous efgartigimod for generalized myasthenia gravis
Tuesday March 22nd 2022
Read more
-
V-Bio Ventures’ Portfolio Company Precirix raises EUR 80m in Series B to advance its pipeline of precision radiopharmaceuticals
Wednesday March 16th 2022
Read more
-
Confo Therapeutics doses first subjects in Phase 1 clinical trial of CFTX-1554 for the treatment of neuropathic pain
Thursday March 10th 2022
Read more
More info?
Contact us
Ellen Telleir
Communication Coordinator
